Programmed cell death ligand-1 (PD-L1) binding to PD-1 on cytotoxic T lymphocytes (CTLs) blocks their activation and trafficking to tumors, facilitating tumor’s evasion of immune surveillance (5). This evidence concerns the gene PDCD1 and neoplasm.